Clarify the regulatory
Understand the FDA expectations on Biosimilars and updates on the EMA and CDSCO guidelines
Explore different statistical approaches to demonstrate biosimilarity with the reference product
Hear from Dr. Ajaz S. Hussain on Reducing Regulatory Uncertainty in Biosimilar Development.
Practical Case Studies
Hear practical case study insights from Indian and International experts and benefit from live examples.
Take part in timely and opportunistic group discussions around Biosimilars
Extended Q&A sessions
Facilitated answers to your most critical questions around Biosimilars